Actual review of diagnostics and endovascular therapy of intracranial arterial stenoses;Diagnostik und endovaskuläre Therapie intrakranieller arterieller Stenosen

RoFo Fortschritte auf dem Gebiet der Rontgenstrahlen und der Bildgebenden Verfahren

Volumn 183, Issue 2, 2011, Pages 104-111

  Gizewski, E R ^a,b   Weber, R ^a   Forsting, M ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

angioplasty; brain; ischemia infarction; stents; vascular

Indexed keywords

ACETYLSALICYLIC ACID;

ANGIOPLASTY; ARTERY OCCLUSION; CIRCULATION; DIGITAL SUBTRACTION ANGIOGRAPHY; DOPPLER ECHOGRAPHY; ENDOVASCULAR THERAPY; HUMAN; INTRACRANIAL ARTERIAL STENOSIS; MAGNETIC RESONANCE ANGIOGRAPHY; NEUROIMAGING; PRIORITY JOURNAL; REVIEW; STENT; THERAPY; TRANSIENT ISCHEMIC ATTACK;

ANGIOGRAPHY, DIGITAL SUBTRACTION; ANGIOPLASTY; ASPIRIN; BRAIN INFARCTION; BRAIN ISCHEMIA; CEREBRAL ANGIOGRAPHY; ECHOENCEPHALOGRAPHY; FIBRINOLYTIC AGENTS; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE; STENTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79551525751     PISSN: 14389029     EISSN: 14389010     Source Type: Journal    
DOI: 10.1055/s-0029-1245708     Document Type: Review

References (51)

1. Caplan L R., Hennerici M. Impaired clearance of emboli (washout) is an important link between hypoperfusion, embolism, and ischemic stroke. Arch Neurol 1998 55 1475-1482
2. Gorelick P B., Wong K S., Bae H J. et al. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke 2008 39 2396-2399
3. McTaggart R A., Jayaraman M V., Haas R A. et al. Intracranial atherosclerotic disease: epidemiology, imaging and treatment. Med Health R I 2009 92 412-414
4. Shin D H., Lee P H., Bang O Y. Mechanisms of recurrence in subtypes of ischemic stroke: a hospital-based follow-up study. Arch Neurol 2005 62 1232-1237
5. Weimar C, Goertler M, Harms L et al. Distribution and outcome of symptomatic stenoses and occlusions in patients with acute cerebral ischemia. Arch Neurol 2006 63 1287-1291
6. Chimowitz M I., Lynn M J., Howlett-Smith H et al. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl J Med 2005 352 1305-1316
7. Chaturvedi S, Turan T N., Lynn M J. et al. Risk factor status and vascular events in patients with symptomatic intracranial stenosis. Neurology 2007 69 2063-2068
8. Kasner S E., Chimowitz M I., Lynn M J. et al. Predictors of ischemic stroke in the territory of a symptomatic intracranial arterial stenosis. Circulation 2006 113 555-563
9. Mazighi M, Tanasescu R, Ducrocq X et al. Prospective study of symptomatic atherothrombotic intracranial stenoses: the GESICA study. Neurology 2006 66 1187-1191
10. Wong K S., Ng P W., Tang A et al. Prevalence of asymptomatic intracranial atherosclerosis in high-risk patients. Neurology 2007 68 2035-2038
11. Dorfler A, Struffert T, Engelhorn T et al. Rotational flat-panel computed tomography in diagnostic and interventional neuroradiology. Fortschr Röntgenstr 2008 180 891-898
12. Kaufmann T J., Huston 3 rd J, Mandrekar J N. et al. Complications of diagnostic cerebral angiography: evaluation of 19,826 consecutive patients. Radiology 2007 243 812-819
13. Droste D W., Junker K, Hansberg T et al. Circulating microemboli in 33 patients with intracranial arterial stenosis. Cerebrovasc Dis 2002 13 26-30
14. Allendoerfer J, Goertler M, Reutern G M. Prognostic relevance of ultra-early doppler sonography in acute ischaemic stroke: a prospective multicentre study. Lancet Neurol 2006 5 835-840
15. Kaps M von, Stolz E, Allendoerfer J. Prognostic value of transcranial sonography in acute stroke patients. Eur Neurol 2008 59 9-16
16. Feldmann E, Wilterdink J L., Kosinski A et al. The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007 68 2099-2106
17. Baumgartner R W., Mattle H P., Schroth G. Assessment of 50 % and < 50 % intracranial stenoses by transcranial color-coded duplex sonography. Stroke 1999 30 87-92
18. Postert T, Federlein J, Przuntek H et al. Insufficient and absent acoustic temporal bone window: potential and limitations of transcranial contrast-enhanced color-coded sonography and contrast-enhanced power-based sonography. Ultrasound Med Biol 1997 23 857-862
19. Choi C G., Lee D H., Lee J H. et al. Detection of intracranial atherosclerotic steno-occlusive disease with 3D time-of-flight magnetic resonance angiography with sensitivity encoding at 3 T. AJNR Am J Neuroradiol 2007 28 439-446
20. Gizewski E R., Ladd M E., Paul A et al. Water Excitation: A Possible Pitfall in Cerebral Time-of-Flight Angiography. AJNR Am J Neuroradiol 2005 26 152-155
21. Anzalone N. Contrast-enhanced MRA of intracranial vessels. Eur Radiol 2005 15 E3-E10
22. Nael K, Ruehm S G., Michaely H J. et al. High spatial-resolution CE-MRA of the carotid circulation with parallel imaging: comparison of image quality between 2 different acceleration factors at 3.0 Tesla. Invest Radiol 2006 41 391-399
23. Nguyen-Huynh M N., Wintermark M, English J et al. How accurate is CT angiography in evaluating intracranial atherosclerotic disease? Stroke 2008 39 1184-1188
24. Bash S, Villablanca J P., Jahan R et al. Intracranial vascular stenosis and occlusive disease: evaluation with CT angiography, MR angiography, and digital subtraction angiography. AJNR Am J Neuroradiol 2005 26 1012-1021
25. Sadikin C, Teng M M., Chen T Y. et al. The current role of 1.5 T non-contrast 3D time-of-flight magnetic resonance angiography to detect intracranial steno-occlusive disease. J Formos Med Assoc 2007 106 691-699
26. Weber W, Mayer T E., Henkes H et al. Efficacy of stent angioplasty for symptomatic stenoses of the proximal vertebral artery. Eur J Radiol 2005 56 240-247 (Pubitemid 41486995)
27. Fiorella D, Chow M M., Anderson M et al. A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease. Neurosurgery 2007 61 236-242; discussion 242 - 233
28. Bose A, Hartmann M, Henkes H et al. A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses: the Wingspan study. Stroke 2007 38 1531-1537
29. Turk A S., Niemann D B., Ahmed A et al. Use of self-expanding stents in distal small cerebral vessels. AJNR Am J Neuroradiol 2007 28 533-536
30. Mazighi M, Yadav J S., Abou-Chebl A. Durability of endovascular therapy for symptomatic intracranial atherosclerosis. Stroke 2008 39 1766-1769
31. Wittkugel O, Rosenkranz M, Burckhardt D et al. Long-term outcome after endovascular treatment of high-risk patients with recurrently symptomatic intracranial stenoses of the posterior circulation. Fortschr Röntgenstr 2009 181 782-791
32. Rezende M T., Spelle L, Mounayer C et al. Hyperperfusion syndrome after stenting for intracranial vertebral stenosis. Stroke 2006 37 e12-e14
33. Choo K S., Lee T H., Choi C H. et al. Assessment of the Intracranial Stents Patency and Re-Stenosis by 16-Slice CT Angiography with Optimized Sharp Kernel: Preliminary Study. J Korean Neurosurg Soc 2009 45 284-288
34. Benesch C G., Chimowitz M I. Best treatment for intracranial arterial stenosis? 50 years of uncertainty. The WASID Investigators. Neurology 2000 55 465-466
35. Diener H C., Aichner F, Bode C. Primär- und Sekundärprophylaxe der zerebralen Ischämie. in Diener H C. Puzki N (eds) Leitlinien für Diagnostik und Therapie in der Neurologie. vol 1. Stuttgart, New York Thieme 2008 261-287
36. Kharbanda R K., Walton B, Allen M et al. Prevention of inflammation-induced endothelial dysfunction: a novel vasculo-protective action of aspirin. Circulation 2002 105 2600-2604
37. Campbell C L., Smyth S, Montalescot G et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review. Jama 2007 297 2018-2024 (Pubitemid 46740354)
38. Kwon S U., Cho Y J., Koo J S. et al. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis: the multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intracranial arterial stenosis. Stroke 2005 36 782-786
39. Sundt T M., Smith H C., Campbell J K. et al. Transluminal angioplasty for basilar artery stenosis. Mayo Clin Proc 1980 55 673-680
40. SSYCVIA Study Investigators. Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA): study results. Stroke 2004 35 1388-1392
41. Derdeyn C P., Chimowitz M I. Angioplasty and stenting for atherosclerotic intracranial stenosis: rationale for a randomized clinical trial. Neuroimaging Clin N Am 2007 17 355-363, viii-ix
42. Marks M P., Wojak J C., Al-Ali F Jr et al. Angioplasty for symptomatic intracranial stenosis: clinical outcome. Stroke 2006 37 1016-1020
43. Wojak J C., Dunlap D C., Hargrave K R. et al. Intracranial angioplasty and stenting: long-term results from a single center. AJNR Am J Neuroradiol 2006 27 1882-1892
44. Lylyk P, Vila J F., Miranda C et al. Endovascular reconstruction by means of stent placement in symptomatic intracranial atherosclerotic stenosis. Neurol Res 2005 27 S84-S88
45. Cruz-Flores S, Diamond A L. Angioplasty for intracranial artery stenosis. Cochrane Database Syst Rev 2006 3 CD004133
46. Groschel K, Schnaudigel S, Pilgram S M. et al. A systematic review on outcome after stenting for intracranial atherosclerosis. Stroke 2009 40 e340-e347
47. Zaidat O O., Klucznik R, Alexander M J. et al. The NIH registry on use of the Wingspan stent for symptomatic 70 - 99 % intracranial arterial stenosis. Neurology 2008 70 1518-1524
48. Kurre W, Berkefeld J, Brassel F et al. In-Hospital Complication Rates After Stent Treatment of 388 Symptomatic Intracranial Stenoses. Results From the INTRASTENT Multicentric Registry. Stroke 2010 41 494-498
49. Siddiq F, Vazquez G, Memon M Z. et al. Comparison of primary angioplasty with stent placement for treating symptomatic intracranial atherosclerotic diseases: a multicenter study. Stroke 2008 39 2505-2510
50. Turk A S., Levy E I., Albuquerque F C. et al. Influence of patient age and stenosis location on wingspan in-stent restenosis. AJNR Am J Neuroradiol 2008 29 23-27
51. Boy S, Isenhardt K, Gardill K et al. [Interventional endovascular therapy (stenting) for residual stenosis after lysis of the basilar artery]. Nervenarzt 2005 76 1488, 1490-1482, 1494